Location History:
- Rathway, NJ (US) (2015)
- Rahway, NJ (US) (2015 - 2016)
- Iselin, NJ (US) (2014 - 2017)
- Gaithersburg, MD (US) (2022 - 2024)
Company Filing History:
12 out of 2,405 
4 out of 28 Years Active: 2014-2024
Title: Innovator Spotlight: Aurash Shahripour - Pioneering Inventor in PCSK9 Inhibition
Introduction:
In the realm of innovations and patents, Aurash Shahripour stands out as a remarkable inventor known for his groundbreaking work in PCSK9 inhibition. With a location in Iselin, NJ (US), he has been granted 10 patents, demonstrating his relentless pursuit of cutting-edge discoveries in the field of biochemistry and pharmaceuticals.
Latest Patents:
Aurash Shahripour's recent patents focus on the development of cyclic polypeptides for the inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). These cyclic polypeptide compounds have the potential to specifically bind to human PCSK9 and may also inhibit the interaction between PCSK9 and the human low-density lipoprotein receptor (LDLR). Such inventions have opened new avenues for combating cardiovascular diseases and reducing LDL cholesterol levels in patients.
Career Highlights:
Throughout his illustrious career, Aurash Shahripour has achieved numerous milestones and received recognition for his innovative work. His dedication to scientific research and development has propelled him to the forefront of the field. With each patent, he has demonstrated his keen ability to translate scientific theories into practical applications that have the potential to revolutionize healthcare.
Collaborations:
Aurash Shahripour's collaborative efforts with leading companies and research institutions have further cemented his reputation as a visionary inventor. Notably, he has worked closely with esteemed organizations such as Merck Sharp & Dohme Corporation, where his expertise has been instrumental in advancing pharmaceutical research. Additionally, his contributions at Ra Pharmaceuticals, Inc., have further showcased his ability to work alongside talented coworkers such as Alexander Pasternak and Haifeng Tang.
Conclusion:
Aurash Shahripour's pioneering work in PCSK9 inhibition through his patented cyclic polypeptide compounds has paved the way for significant advancements in the treatment of cardiovascular diseases. His relentless pursuit of innovative solutions, coupled with his collaborations with prominent organizations, underlines his impact in the field. As the world of innovations and patents continues to evolve, Aurash Shahripour's groundbreaking inventions are set to make a lasting impact on the realm of pharmaceutical research and healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.